Effect of intravenous zoledronic acid (ZA) on bone metastasis in patients with metastatic renal cell cancer (mRCC)

被引：0
|
作者：
Gruenwald, V. [1 ]
Wirth, M. [2 ]
Zantl, N. [3 ]
Schulze, M.
May, C. [4 ]
Ruebel, A. [4 ]
Tunn, U. [5 ]
机构：
[1] Hannover Med Sch, D-30623 Hannover, Germany
[2] Univ Klinikum Carl Gustav Carus Dresden, Dresden, Germany
[3] Klinikum Konstanz, Constance, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
[5] Stadt Kliniken Offenbach, Offenbach, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [11] Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid
    Sachin R. Shah
    Gary W. Jean
    Sidney V. Keisner
    Sarah M. Gressett Ussery
    Jonathan E. Dowell
    Supportive Care in Cancer, 2012, 20 : 87 - 93
  • [12] Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid
    Shah, Sachin R.
    Jean, Gary W.
    Keisner, Sidney V.
    Ussery, Sarah M. Gressett
    Dowell, Jonathan E.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (01) : 87 - 93
  • [13] EFFICACY OF ZOLEDRONIC ACID IN PATIENTS WITH COLORECTAL CANCER METASTATIC TO BONE
    Tonini, G.
    Loupakis, F.
    Berardi, R.
    Badalamenti, G.
    Addeo, R.
    Ortega, C.
    Sabbatini, R.
    Vendititi, O.
    Virzi, V.
    Santini, D.
    ANNALS OF ONCOLOGY, 2010, 21 : 203 - 203
  • [14] Efficacy of zoledronic acid in patients with colorectal cancer metastatic to bone
    Santini, D.
    Loupakis, F.
    Berardi, R.
    Badalamenti, G.
    Addeo, L.
    Ortega, C.
    Sabbatini, R.
    Venditti, O.
    Virzi, V.
    Vincenzi, B.
    Tonini, G.
    BONE, 2011, 48 (01) : S23 - S24
  • [15] BONE METASTASES IN NSCLC: THE ANTIANGIOGENIC EFFECT OF ZOLEDRONIC ACID (ZA)
    Quirino, M.
    Orlandi, A.
    Quaranta, A.
    Strippoli, A.
    Cursio, O. E.
    Di Lascio, S.
    Amoruso, A.
    Basso, M.
    Cassano, A.
    Barone, C.
    LUNG CANCER, 2011, 71 : S32 - S32
  • [16] Prognostic impact of lymphnode metastasis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Ivanyi, P.
    Tiemann, M. -L.
    Eggers, H.
    Reuter, C.
    Peters, I.
    Kuczyk, M.
    Ganser, A.
    Gruenwald, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 80 - 80
  • [17] Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease
    Nina V. Lyubimova
    Nikolay E. Kushlinsky
    Michail R. Lichinitser
    Karl Schlosser
    Clinical Drug Investigation, 2003, 23 : 707 - 716
  • [18] Renal safety of intravenous ibandronic acid in breast cancer patients with metastatic bone disease
    Lyubimova, NV
    Kushlinsky, NE
    Lichinitser, MR
    Schlosser, K
    CLINICAL DRUG INVESTIGATION, 2003, 23 (11) : 707 - 716
  • [19] Effect of immunotherapy (IO) on primary renal tumor in metastatic renal cell cancer (mRCC).
    Jamet, Antoine
    Caramella, Caroline
    Guida, Annalisa
    Arfi-Rouche, Julia
    Merabet, Zahira
    Colomba, Emeline
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [20] The effect of zoledronic acid on bone metastasis in patients suffering from renal cell cancer (RCC): A German prospective single-arm clinical trial
    Tunn, U.
    Stenzl, A.
    Kindler, M.
    Strauss, A.
    Miller, K.
    Ruebel, A.
    Albrecht, M.
    Gruenwald, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345